Angiotensin-2 type 1 receptors (AT1R) and cancers;Récepteurs de type 1 à l'angiotensine-2 (AT1R) et cancers

Nephrologie et Therapeutique

Volumn 9, Issue 2, 2013, Pages 85-91

  Dolley Hitze, Thibault ^a,b   Verhoest, Grégory ^a,b   Jouan, Florence ^b   Le Pogamp, Patrick ^a   Arlot Bonnemains, Yannick ^b   Oger, Emmanuel ^a   Belaud Rotureau, Marc Antoine ^a,b   Rioux Leclercq, Nathalie ^a,b   Vigneau, Cécile ^a,b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Angiotensin 2; Antagonists of angiotensin 2 receptors; AT1R; Cancer; Inhibitors of angiotensinogen converting enzyme

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; META ANALYSIS (TOPIC); NEOPLASM; NONHUMAN; TUMOR CELL CULTURE;

EID: 84875886451     PISSN: 17697255     EISSN: 18729177     Source Type: Journal    
DOI: 10.1016/j.nephro.2012.09.006     Document Type: Short Survey

References (71)

1. I. Sipahi, S.M. Debanne, D.Y. Rowland, D.I. Simon, and J.C. Fang Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials Lancet Oncol 11 2010 627 636
2. P.A. Meredith, and G.T. McInnes Angiotensin-receptor blockade, cancer, and concerns Lancet Oncol 11 2010 819 [author reply 812-821]
3. I. Sipahi, J. Chou, P. Mishra, S.M. Debanne, D.I. Simon, and J.C. Fang Meta-analysis of randomized controlled trials on effect of angiotensin- converting enzyme inhibitors on cancer risk Am J Cardiol 108 2011 294 301
4. The ARB trialists collaboration Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals J Hypertens 29 2011 623 635
5. A.F. Lever, D.J. Hole, C.R. Gillis, I.R. McCallum, G.T. McInnes, and P.L. MacKinnon Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352 1998 179 184
6. C.C. Huang, W.L. Chan, Y.C. Chen, T.J. Chen, S.J. Lin, and J.W. Chen Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension Am J Cardiol 107 2011 1028 1033
7. C.H. Chang, J.W. Lin, L.C. Wu, and M.S. Lai Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study J Clin Oncol 29 2011 3001 3007
8. B. Pasternak, H. Svanstrom, T. Callreus, M. Melbye, and A. Hviid Use of angiotensin receptor blockers and the risk of cancer Circulation 123 2011 1729 1736
9. S. Wilop, S. von Hobe, M. Crysandt, A. Esser, R. Osieka, and E. Jost Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy J Cancer Res Clin Oncol 135 2009 1429 1435
10. D. Keizman, P. Huang, M.A. Eisenberger, R. Pili, J.J. Kim, and E.S. Antonarakis Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination Eur J Cancer 47 2011 1955 1961
11. M. Tatokoro, Y. Fujii, S. Kawakami, N. Fukui, Y. Komai, and K. Saito Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: report of three cases Int J Urol 15 2008 848 850
12. Y.K. Chae, M.E. Valsecchi, J. Kim, A.L. Bianchi, D. Khemasuwan, and A. Desai Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins Cancer Invest 29 2011 585 593
13. S. Lukic, A. Nikolic, T. Alempijevic, D. Popovic, A. Sokic Milutinovic, and M. Ugljesic Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer Dig Surg 28 2011 258 262
14. M. Sun, C. Liu, F. Wei, J. Zhong, and Y. Sun Association of angiotensin I converting enzyme insertion/deletion polymorphism with breast cancer: a meta-analysis J Renin Angiotensin Aldosterone Syst 12 2011 611 616
15. B. Xi, T. Zeng, L. Liu, Y. Liang, W. Liu, and Y. Hu Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis Breast Cancer Res Treat 130 2011 561 568
16. V.F. Norwood, M.R. Craig, J.M. Harris, and R.A. Gomez Differential expression of angiotensin II receptors during early renal morphogenesis Am J Physiol 272 1997 R662 R668
17. V.J. Dzau, J. Ingelfinger, R.E. Pratt, and K.E. Ellison Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains Hypertension 8 1986 544 548
18. D.J. Campbell, and J.F. Habener Hybridization in situ studies of angiotensinogen gene expression in rat adrenal and lung Endocrinology 124 1989 218 222
19. R. Re The myocardial intracellular renin-angiotensin system Am J Cardiol 59 1987 56A 58A
20. D.J. Campbell, J. Bouhnik, J. Menard, and P. Corvol Identity of angiotensinogen precursors of rat brain and liver Nature 308 1984 206 208
21. J.R. Skipworth, G. Szabadkai, S.W. Olde Damink, P.S. Leung, S.E. Humphries, and H.E. Montgomery Review article: pancreatic renin-angiotensin systems in health and disease Aliment Pharmacol Ther 34 2011 840 852
22. H. Matsubara, T. Sugaya, S. Murasawa, Y. Nozawa, Y. Mori, and H. Masaki Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization Nephron 80 1998 25 34
23. L. Juillerat-Jeanneret, J. Celerier, C. Chapuis Bernasconi, G. Nguyen, W. Wostl, and H.P. Maerki Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma Br J Cancer 90 2004 1059 1068
24. T. Dolley-Hitze, F. Jouan, B. Martin, S. Mottier, J. Edeline, and O. Moranne Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma Br J Cancer 103 2010 1698 1705
25. D.R. Rhodes, B. Ateeq, Q. Cao, S.A. Tomlins, R. Mehra, and B. Laxman AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist Proc Natl Acad Sci U S A 106 2009 10284 10289
26. J. Kinoshita, S. Fushida, S. Harada, Y. Yagi, H. Fujita, and S. Kinami Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin Int J Oncol 34 2009 1573 1582
27. S. Shirotake, A. Miyajima, T. Kosaka, N. Tanaka, T. Maeda, and E. Kikuchi Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer Urology 77 2011 1009 [e1019-1025]
28. O. Arrieta, B. Pineda-Olvera, P. Guevara-Salazar, N. Hernandez-Pedro, D. Morales-Espinosa, and T.L. Ceron-Lizarraga Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis Br J Cancer 99 2008 160 166
29. T. Suganuma, K. Ino, K. Shibata, H. Kajiyama, T. Nagasaka, and S. Mizutani Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination Clin Cancer Res 11 2005 2686 2694
30. H. Takeda, and S. Kondo Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression Am J Pathol 158 2001 1633 1637
31. Y. Fujimoto, T. Sasaki, A. Tsuchida, and K. Chayama Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist FEBS Lett 495 2001 197 200
32. M. Pawlikowski, K. Winczyk, and B. Sledz Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors Folia Histochem Cytobiol 46 2008 51 55
33. K. Ino, K. Shibata, H. Kajiyama, E. Yamamoto, T. Nagasaka, and A. Nawa Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival Br J Cancer 94 2006 552 560
34. C. Rocken, F.W. Rohl, E. Diebler, U. Lendeckel, M. Pross, and S. Carl-McGrath The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer Cancer Epidemiol Biomarkers Prev 16 2007 1206 1212
35. F. Kikkawa, M. Mizuno, K. Shibata, H. Kajiyama, T. Morita, and K. Ino Activation of invasiveness of cervical carcinoma cells by angiotensin II Am J Obstet Gynecol 190 2004 1258 1263
36. R. Anandanadesan, Q. Gong, G. Chipitsyna, A. Witkiewicz, C.J. Yeo, and H.A. Arafat Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling J Gastrointest Surg 12 2008 57 66
37. M. Kosugi, A. Miyajima, E. Kikuchi, T. Kosaka, Y. Horiguchi, and M. Murai Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer Hum Cell 20 2007 1 9
38. Y. Zhao, X. Chen, L. Cai, Y. Yang, G. Sui, and S. Fu Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway J Cell Physiol 225 2010 168 173
39. S.K. Bose, W. Gibson, S. Giri, N. Nath, and C.D. Donald Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor Prostate 69 2009 1334 1342
40. S. Fujiyama, H. Matsubara, Y. Nozawa, K. Maruyama, Y. Mori, and Y. Tsutsumi Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation Circ Res 88 2001 22 29
41. S. Greco, A. Muscella, M.G. Elia, P. Salvatore, C. Storelli, and A. Mazzotta Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells J Cell Physiol 196 2003 370 377
42. H. Uemura, H. Ishiguro, N. Nakaigawa, Y. Nagashima, Y. Miyoshi, and K. Fujinami Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor Mol Cancer Ther 2 2003 1139 1147
43. Y. Zhao, X. Chen, L. Cai, Y. Yang, G. Sui, and J. Wu Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase/Akt signaling in human breast cancer cells Acta Biochim Biophys Sin (Shanghai) 40 2008 304 310
44. D. Herr, M. Rodewald, H.M. Fraser, G. Hack, R. Konrad, and R. Kreienberg Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer Gynecol Oncol 109 2008 418 425
45. T. Kosaka, A. Miyajima, S. Shirotake, E. Kikuchi, M. Hasegawa, and S. Mikami Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer Prostate 70 2010 162 169
46. H.A. Arafat, Q. Gong, G. Chipitsyna, A. Rizvi, C.T. Saa, and C.J. Yeo Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma J Am Coll Surg 204 2007 996 1005 [discussion 1005-6]
47. W. Huang, Y.L. Wu, J. Zhong, F.X. Jiang, X.L. Tian, and L.F. Yu Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts Dig Dis Sci 53 2008 1206 1210
48. J. Wasa, H. Sugiura, E. Kozawa, K. Kohyama, K. Yamada, and O. Taguchi The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model Anticancer Res 31 2011 123 127
49. L. Chow, L. Rezmann, K. Imamura, L. Wang, K. Catt, and C. Tikellis Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines Prostate 68 2008 651 660
50. A.H. Otake, A.L. Mattar, H.C. Freitas, C.M. Machado, S. Nonogaki, and C.K. Fujihara Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma Cancer Chemother Pharmacol 66 2010 79 87
51. N. Du, J. Feng, L.J. Hu, X. Sun, H.B. Sun, and Y. Zhao Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling Oncol Rep 27 2012 1893 1903
52. A. Miyajima, T. Asano, and M. Hayakawa Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells J Urol 165 2001 616 620
53. L. Wang, S.R. Cai, C.H. Zhang, Y.L. He, W.H. Zhan, and H. Wu Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chin Med J (Engl) 121 2008 2167 2171
54. Q. Gong, M. Davis, G. Chipitsyna, C.J. Yeo, and H.A. Arafat Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells Pancreas 39 2010 581 594
55. S.A. Arnold, L.B. Rivera, J.G. Carbon, J.E. Toombs, C.L. Chang, and A.D. Bradshaw Losartan slows pancreatic tumor progression and extends survival of SPARC-Null mice by abrogating aberrant TGFbeta activation PLoS One 7 2012 e31384
56. H. Uemura, H. Ishiguro, Y. Ishiguro, K. Hoshino, S. Takahashi, and Y. Kubota Angiotensin II induces oxidative stress in prostate cancer Mol Cancer Res 6 2008 250 258
57. N. Chehl, Q. Gong, G. Chipitsyna, T. Aziz, C.J. Yeo, and H.A. Arafat Angiotensin II regulates the expression of monocyte chemoattractant protein-1 in pancreatic cancer cells J Gastrointest Surg 13 2009 2189 2200
58. A. Spychalowicz, G. Wilk, T. Sliwa, D. Ludew, and T.J. Guzik Novel therapeutic approaches in limiting oxidative stress and inflammation Curr Pharm Biotechnol 2012 [Jan 20. Epub ahead of print]
59. J.H. Neo, E.I. Ager, P.W. Angus, J. Zhu, C.B. Herath, and C. Christophi Changes in the renin angiotensin system during the development of colorectal cancer liver metastases BMC Cancer 10 2010 134
60. A. Miyajima, T. Kosaka, T. Asano, K. Seta, T. Kawai, and M. Hayakawa Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis Cancer Res 62 2002 4176 4179
61. J.R. Puddefoot, U.K. Udeozo, S. Barker, and G.P. Vinson The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion Endocr Relat Cancer 13 2006 895 903
62. V. Fendrich, N.M. Chen, M. Neef, J. Waldmann, M. Buchholz, and G. Feldmann The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer Gut 59 2010 630 637
63. K. Suzuki, G.D. Han, N. Miyauchi, T. Hashimoto, T. Nakatsue, and Y. Fujioka Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall Am J Pathol 170 2007 1841 1853
64. A. Kawabata, A. Baoum, N. Ohta, S. Jacquez, G.M. Seo, and C. Berkland Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth Cancer Res 72 2012 2057 2067
65. S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, and A. Fukamizu (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system Am J Pathol 173 2008 1911 1918
66. R.R. Kohl, A. Kolozsvary, S.L. Brown, G. Zhu, and J.H. Kim Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor Radiat Res 168 2007 440 445
67. K. Yanase, H. Yoshiji, Y. Ikenaka, R. Noguchi, M. Kitade, and K. Kaji Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities Oncol Rep 17 2007 441 446
68. R. Noguchi, H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, and K. Yanase Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis Clin Cancer Res 9 2003 6038 6045
69. R. Noguchi, H. Yoshiji, Y. Ikenaka, T. Namisaki, M. Kitade, and K. Kaji Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities Oncol Rep 22 2009 355 360
70. H. Uemura, H. Hasumi, T. Kawahara, S. Sugiura, Y. Miyoshi, and N. Nakaigawa Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer Int J Clin Oncol 10 2005 405 410
71. B.N. Becker, S. Kondo, J.K. Chen, and R.C. Harris Tyrosine kinase inhibition affects type 1 angiotensin II receptor internalization J Recept Signal Transduct Res 19 1999 975 993